NetworkNewsBreaks Archive - Page 175 of 2091

FridayMar 21, 2025 1:52 pm

NetworkNewsBreaks – Calidi Biotherapeutics Inc. (NYSE American: CLDI): Poised in the Future of Oncology with Cutting-Edge Treatments

Calidi Biotherapeutics (NYSE American: CLDI) is a clinical-stage biotechnology company at the forefront of research and development of innovative treatments in the field of immuno-oncology. With cancer being the second leading cause of death globally, the company focuses on harnessing antitumor virotherapies and patented technologies designed to protect and potentiate the virotherapy during administration to combat cancer more effectively and with fewer side effects. The company’s approach includes a systemic platform using extracellular enveloped viruses and an intratumoral platform utilizing stem cells to protect the therapy from the body’s immune system during administration. Calidi’s pipeline includes promising therapies such as RTNova,…

FridayMar 21, 2025 12:24 pm

NetworkNewsBreaks – Clene Inc. (NASDAQ: CLNN) Unveils Progress on CNM-Au8(R), Eyes Potential Fast-Track FDA Approval

Clene (NASDAQ: CLNN) and its wholly owned subsidiary, Clene Nanomedicine Inc., a late clinical-stage biopharmaceutical company focused on improving mitochondrial health and protecting neuronal function to treat neurodegenerative diseases, including amyotrophic lateral sclerosis (“ALS”) and multiple sclerosis (“MS”), is actively advancing its lead drug candidate, CNM-Au8®. The company presented its progress at two key investor events this month, including the Q1 Virtual Investor Summit and the 37th Annual Roth Conference. At both events, Clene’s management discussed the latest achievements with CNM-Au8, a gold nanocrystal-based oral suspension that targets mitochondrial dysfunction and promotes neuronal health. The drug has shown promising results in…

FridayMar 21, 2025 11:50 am

NetworkNewsBreaks – Soligenix Inc. (NASDAQ: SNGX) Announces Key Milestones and 2024 Financial Results

Soligenix (NASDAQ: SNGX), a late-stage biopharmaceutical company focused on developing and commercializing products to treat rare diseases where there is an unmet medical need, today announced its recent accomplishments and financial results for the year ended Dec. 31, 2024. “We remain highly focused on advancing our multiple clinical programs as we work towards achieving a number of important and potentially transformational development milestones, including top-line results in 2026 for our actively enrolling confirmatory Phase 3 placebo-controlled study evaluating HyBryte(TM) (synthetic hypericin) in the treatment of early-stage cutaneous T-cell lymphoma (‘CTCL’),” stated Christopher J. Schaber, PhD, president and chief executive officer…

FridayMar 21, 2025 10:16 am

NetworkNewsBreaks – General Mills, Inc. (NYSE: GIS) Reports Mixed Q3 2025 Results, Updates Outlook

General Mills (NYSE: GIS) announced its third-quarter fiscal 2025 results, reporting earnings per share (“EPS”) of $1.00, surpassing analyst expectations of $0.98. However, revenue fell short, totaling $4.8 billion against a projected $4.99 billion. The company attributed the revenue miss to greater-than-expected retailer inventory headwinds and a slowdown in U.S. snacking categories. In response, General Mills plans to invest in consumer value, media support, and in-store visibility in the fourth quarter to drive growth. To view the full article, visit https://nnw.fm/9OrCk About General Mills General Mills makes food the world loves. The company is guided by its Accelerate strategy to…

FridayMar 21, 2025 9:49 am

NetworkNewsBreaks – D-Wave Quantum Inc. (NYSE: QBTS) Unveils Quantum-Powered Blockchain Architecture

D-Wave Quantum Inc. (NYSE: QBTS) (“D-Wave”), a leader in quantum computing systems, software, and services, has introduced a novel blockchain architecture that incorporates quantum computing techniques to enhance security and efficiency. The company’s new research paper, Blockchain with Proof of Quantum Work, details how a “proof of quantum” algorithm utilizes quantum computation to generate and validate blockchain hashes. D-Wave deployed this architecture across four of its cloud-based annealing quantum computers located in Canada and the U.S., marking the first instance of distributed quantum computing for blockchain. The research indicates that using quantum computation for hashing and proof of work could…

ThursdayMar 20, 2025 1:45 pm

NetworkNewsBreaks – Thumzup Media Corp. (NASDAQ: TZUP) Repurchases $126,507 in Common Stock

Thumzup (NASDAQ: TZUP), a growing force in social media branding and programmatic marketing, announced the repurchase of $126,507 of its common stock as part of its previously approved $1 million buyback program. The company views the repurchase as a strategic move to enhance shareholder value and reinforce confidence in its growth trajectory. CEO Robert Steele highlighted the buyback as a demonstration of Thumzup's commitment to capital efficiency and long-term value creation. The company has also reported surpassing 700 advertisers on its platform, with a compound annual growth rate exceeding 200%. To view the full press release, visit https://nnw.fm/ggcaF About Thumzup® …

ThursdayMar 20, 2025 11:52 am

NetworkNewsBreaks – NVIDIA Corp. (NASDAQ: NVDA) Commits to U.S. Manufacturing Amid AI Industry Growth

NVIDIA (NASDAQ: NVDA) plans to invest hundreds of billions of dollars in U.S. chip manufacturing over the next four years, aligning with President Donald Trump's initiatives to bolster the artificial intelligence (“AI”) industry and domestic production. CEO Jensen Huang praised the administration's support, stating it creates "phenomenal" opportunities for AI development in the U.S. As of 10:32 AM EDT on March 20, 2025, Nvidia's stock is trading at $118.84, reflecting an increase of $1.32 (1.12%) from the previous close. To view the full article, visit https://nnw.fm/bRlum About NVIDIA Corp. NVIDIA Corp. is a leading technology company specializing in graphics…

ThursdayMar 20, 2025 11:32 am

NetworkNewsBreaks – Hello Group Inc. (NASDAQ: MOMO) Upgraded to ‘Buy’ by Huatai Securities With $11.69 Target

Hello Group (NASDAQ: MOMO), received an upgrade from Huatai Securities, which raised the stock's rating to "Buy" and set a target price of $11.69. The firm cited the company's strong user engagement and revenue growth potential as key factors in its revised outlook. Hello Group, known for its Momo and Tantan social networking platforms, continues to expand its influence in China's online dating and social discovery market. As of the latest trading session, Hello Group’s stock is priced at $6.77, reflecting a decrease of $0.14 (2.03%) from the previous close. To view the full article, visit https://nnw.fm/oGDzt About Hello Group…

ThursdayMar 20, 2025 11:00 am

NetworkNewsBreaks – Apple Inc. (NASDAQ: AAPL) Loses Top Health Executive to Oura, Fueling Smart Ring Market Growth

Apple (NASDAQ: AAPL) has lost a key executive from its health division, as Dr. Ricky Bloomfield, formerly the Clinical and Health Informatics Lead, departs to join Oura as its Chief Medical Officer. Bloomfield played a critical role in shaping Apple’s health strategy, including its push into digital health records and wearable health tracking. His move to Oura, a company specializing in smart rings for health monitoring, signals growing competition in the wearable health-tech space, with some analysts seeing it as a potential shift in consumer interest toward ring-based health tracking over smartwatches. As of the latest trading session, Apple’s stock is…

ThursdayMar 20, 2025 10:50 am

NetworkNewsBreaks – Match Group Inc. (NASDAQ: MTCH) Faces Proxy Battle as Anson Funds Seeks Board Changes

Match Group (NASDAQ: MTCH), s confronting a proxy challenge from hedge fund Anson Funds, which plans to nominate directors to the company’s 10-member board. Anson, holding approximately 0.6% of Match Group’s shares as of December, has been advocating for over a year for the parent company of Tinder, Hinge, and OkCupid to reassess capital allocation, reduce costs, and evaluate its MG Asia business. The hedge fund has also expressed concerns about corporate governance and executive turnover, noting that Match Group has had four CEOs in five years. As of 10:30 AM EDT on March 20, 2025, Match Group’s stock is…

Financial news and publishing for public and private companies

Contact us: 512.354.7000

NetworkNewsBreaks